Literature DB >> 8049458

Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.

Y S López-Boado1, I Díez-Itza, J Tolivia, C López-Otín.   

Abstract

We have studied the hormonal regulation of the gene encoding Zn-alpha 2-glycoprotein (Zn-alpha 2-gp), a human protein with a high degree of amino acid sequence similarity to class I histocompatibility antigens that is produced by a specific subset of breast carcinomas. Northern blot analysis revealed that dexamethasone and 5 alpha-dihydrotestosterone strongly induced the accumulation of Zn-alpha 2-gp mRNA in T-47D human breast cancer cells. Furthermore, the effect of these two hormones was shown to be additive, since the combination of both hormones produced a stimulation of Zn-alpha 2-gp mRNA of at least 3-fold over that produced by either hormone alone. By contrast, the addition of 5 beta-dihydrotestosterone, 17 beta-estradiol, or progesterone failed to induce the expression of Zn-alpha 2-gp. The stimulatory effect of glucocorticoids and androgens on Zn-alpha 2-gp expression was produced in a time and dose dependent manner, without significantly affecting the cell proliferation rate. A time-course study demonstrated that the induction of Zn-alpha 2-gp mRNA by androgens and glucocorticoids reached a level of 4 or 3.2-fold over the untreated control after seven days of incubation in the presence of a 10(-7) M concentration of 5 alpha-dihydrotestosterone or dexamethasone, respectively. A dose-response study showed that as little as 10(-11) M of 5 alpha-dihydrotestosterone or dexamethasone produced an accumulation of Zn-alpha 2-gp mRNA of 2.4 or 2.1-fold over the control, respectively. On the basis of these results, we propose that Zn-alpha2-gp may be useful as a biochemical marker of breast carcinomas with a specific pattern of hormone responsiveness in whose development glucocorticoids and/or androgens may play a significant role.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049458     DOI: 10.1007/bf00666478

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  48 in total

Review 1.  Breast cancer (1)

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-07-30       Impact factor: 91.245

2.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

3.  The level of Zn-alpha 2-glycoprotein in normal human body fluids and kidney extract.

Authors:  J R Poortmans; K Schmid
Journal:  J Lab Clin Med       Date:  1968-05

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.

Authors:  D Chalbos; H Rochefort
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

6.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).

Authors:  D Chalbos; F Vignon; I Keydar; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

7.  Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.

Authors:  J Simard; S Dauvois; D E Haagensen; C Lévesque; Y Mérand; F Labrie
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

8.  Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.

Authors:  W G Dilley; D E Haagensen; G S Leight; S Ammirata; S R Davis; J S Silva; N Zamcheck; J J Lokich; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters.

Authors:  I Díez-Itza; L M Sánchez; M T Allende; F Vizoso; A Ruibal; C López-Otín
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Human Zn-alpha 2-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues.

Authors:  J P Freije; A Fueyo; J Uría; C López-Otín
Journal:  FEBS Lett       Date:  1991-09-23       Impact factor: 4.124

View more
  9 in total

1.  Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes.

Authors:  M G Walker; W Volkmuth; E Sprinzak; D Hodgson; T Klingler
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

2.  Biochemical characterization and crystalization of human Zn-alpha2-glycoprotein, a soluble class I major histocompatibility complex homolog.

Authors:  L M Sánchez; C López-Otín; P J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

3.  Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma.

Authors:  F J Vizoso; M Rodriguez; A Altadill; M L González-Diéguez; A Linares; L O González; S Junquera; F Fresno-Forcelledo; M D Corte; L Rodrigo
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

4.  Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.

Authors:  Chen Bing; Yi Bao; John Jenkins; Paul Sanders; Monia Manieri; Saverio Cinti; Michael J Tisdale; Paul Trayhurn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

5.  Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.

Authors:  Mengliu Yang; Rui Liu; Shu Li; Yu Luo; Yali Zhang; Lili Zhang; Dongfang Liu; Yaxu Wang; Zhengai Xiong; Guenther Boden; Shirong Chen; Ling Li; Gangyi Yang
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

6.  The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia.

Authors:  S T Russell; M J Tisdale
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

7.  Serum ZAG Levels Were Associated with eGFR Mild Decrease in T2DM Patients with Diabetic Nephropathy.

Authors:  Lingling Xu; Weihong Yu; Meng Niu; Caixia Zheng; Bin Qu; Yan Li; Jing Wang; Ping Huang; O Wang; Fengying Gong
Journal:  Int J Endocrinol       Date:  2017-03-02       Impact factor: 3.257

8.  Secreted indicators of androgen receptor activity in breast cancer pre-clinical models.

Authors:  Toru Hanamura; Jessica L Christenson; Kathleen I O'Neill; Emmanuel Rosas; Nicole S Spoelstra; Michelle M Williams; Jennifer K Richer
Journal:  Breast Cancer Res       Date:  2021-11-04       Impact factor: 6.466

9.  Postmenopausal estrogen and progestin effects on the serum proteome.

Authors:  Sharon J Pitteri; Samir M Hanash; Aaron Aragaki; Lynn M Amon; Lin Chen; Tina Busald Buson; Sophie Paczesny; Hiroyuki Katayama; Hong Wang; Melissa M Johnson; Qing Zhang; Martin McIntosh; Pei Wang; Charles Kooperberg; Jacques E Rossouw; Rebecca D Jackson; Joann E Manson; Judith Hsia; Simin Liu; Lisa Martin; Ross L Prentice
Journal:  Genome Med       Date:  2009-12-24       Impact factor: 11.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.